Regeneron Pharmaceuticals announced initiation of the first clinical trial of REGN-COV2, its investigational dual antibody cocktail for the prevention and treatment of COVID-19. Read more...
Johnson & Johnson announced through Janssen Pharmaceutical, it has accelerated the initiation of the Phase 1/2a first-in-human clinical trial of its investigational SARS-CoV-2 vaccine, Ad26.COV2-S, recombinant. Read more...
Vivera Pharmaceuticals has announced the launch of their point-of-care ready rapid serology tests. Read more...
The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to Illumina, for the first COVID-19 diagnostic test utilizing next generation sequence technology. Read more...